OvaCure is proud to announce our official support of the UN Sustainability Goals (SDG):
Goal 3: Ensure healthy lives and promote well-being for all at all ages
Ensuring healthy lives and promoting the well-being for all at all ages is essential to sustainable development. Significant strides have been made in increasing life expectancy and reducing some of the common killers associated with child and maternal mortality. Major progress has been made on increasing access to clean water and sanitation, reducing malaria, tuberculosis, polio and the spread of HIV/AIDS. However, many more efforts are needed to fully eradicate a wide range of diseases and address many different persistent and emerging health issues.
Each of OvaCure's projects have maximum potential for the development of curative treatments for ovarian cancer patients. OvaCure's first five projects are currently underway, with the flagship project, T-cell Infusion, being among the world's first trials to treat ovarian cancer patients with adoptive T-cell therapy (ACT). Through these projects OvaCure supports the UN’s target 3.4.1 of working towards decreasing the mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease.
Goal 5: Achieve gender equality and empower all women and girls
While the world has achieved progress towards gender equality and women’s empowerment under the Millennium Development Goals (including equal access to primary education between girls and boys), women and girls continue to suffer discrimination and violence in every part of the world. Gender equality is not only a fundamental human right, but a necessary foundation for a peaceful, prosperous and sustainable world.
Providing women and girls with equal access to education, health care, decent work, and representation in political and economic decision-making processes will fuel sustainable economies and benefit societies and humanity at large.
OvaCure has aligned employment and leadership positions with the European Equal Treatment Directive 2006/54/EC. Currently, 8 out of 10 of OvaCure's Strategic Advisory Board members are women and 3 out of 6 of the Scientific and Clinical Advisory Board Members are women. Moreover, 3 out of 5 of OvaCure’s Active Projects are led by female principal investigators. This approach supports the UN target 5.5.2. of enhancing the proportion of women in managerial positions.
Goal 17: Revitalize the global partnership for sustainable development
A successful sustainable development agenda requires partnerships between governments, the private sector and civil society. These inclusive partnerships built upon principles and values, a shared vision, and shared goals that place people and the planet at the centre, are needed at the global, regional, national and local level.
Urgent action is needed to mobilize, redirect and unlock the transformative power of trillions of dollars of private resources to deliver on sustainable development objectives. Long-term investments, including foreign direct investment, are needed in critical sectors, especially in developing countries. These include sustainable energy, infrastructure and transport, as well as information and communications technologies. The public sector will need to set a clear direction. Review and monitoring frameworks, regulations and incentive structures that enable such investments must be retooled to attract investments and reinforce sustainable development. National oversight mechanisms such as supreme audit institutions and oversight functions by legislatures should be strengthened.
OvaCure has to-date, catalysed partnerships between Denmark, the United Kingdom, USA, Switzerland, Canada, Germany, France and the Netherlands. Hence, the OvaCure model supports the SDG target no. 17.16 of enhancing global partnerships for sustainable development.
Join our movement and become a member of OvaCure today by emailing email@example.com!